Clinical trial
Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository
NCT03901521 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- June 1, 2018
- Completion date
- December 31, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autosomal dominant polycystic kidney disease